A case of mody 2 - Associated hyperglycemia diagnosed as gestational diabetes

1Anık A, Çatlı G, Abacı A, Böber E. Maturity-onset diabetes of the young (MODY): an update. J Pediatr Endocrinol Metab. 2015; 28(3-4):251-63. doi: 10.1515/jpem-2014-0384. PMID: 25581748.Anık A Çatlı G Abacı A Böber E Maturity-onset diabetes of the young (MODY): an update J Pediatr Endocrinol Metab 2015 283-4251 63 doi 10.1515/jpem-2014-0384. PMID: 25581748Open DOISearch in Google Scholar

2Nkonge KM, Nkonge DK, Nkonge TN. The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY). Clin Diabetes Endocrinol. 2020; 6:20. https://doi.org/10.1186/s40842-020-00112-5.Nkonge KM Nkonge DK Nkonge TN The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY) Clin Diabetes Endocrinol 2020 620 https://doi.org/10.1186/s40842-020-00112-5.10.1186/s40842-020-00112-5764048333292863Search in Google Scholar

3Juszczak A, Pryse R, Schuman A, Owen KR. When to consider a diagnosis of MODY at the presentation of diabetes: aetiology matters for correct management. Br J Gen Pract. 2016; 66(647): e457-e459. doi: 10.3399/bjgp16X685537.Juszczak A Pryse R Schuman A Owen KR When to consider a diagnosis of MODY at the presentation of diabetes: aetiology matters for correct management Br J Gen Pract 2016 66647 e457 e459 doi 10.3399/bjgp16X685537.Open DOISearch in Google Scholar

4Murphy R. Monogenic diabetes and pregnancy. Obstet Med. 2015; 8(3): 114-120. doi: 10.1177/1753495X15590713.Murphy R Monogenic diabetes and pregnancy Obstet Med 2015 83 114 120 doi 10.1177/1753495X15590713.Open DOISearch in Google Scholar

5Misra S, Dornhorst A. Gestational Diabetes Mellitus: Primum Non Nocere. Diabetes Care. 2012; 35(9): 1811-1813. doi: 10.2337/dc12-0689.Misra S Dornhorst A Gestational Diabetes Mellitus: Primum Non Nocere Diabetes Care 2012 359 1811 1813 doi 10.2337/dc12-0689.Open DOISearch in Google Scholar

6Chang X, Wang K. wANNOVAR: annotating genetic variants for personal genomes via the web. J Med Genet. 2012 Jul; 49(7): 433-6. doi: 10.1136/jmedgenet-2012-100918.Chang X Wang K wANNOVAR: annotating genetic variants for personal genomes via the web J Med Genet 2012 Jul 497 433 6 doi 10.1136/jmedgenet-2012-100918355633722717648Open DOISearch in Google Scholar

7Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May; 17(5): 405-24. doi: 10.1038/gim.2015.30.Richards S Aziz N Bale S Bick D Das S Gastier-Foster J et al ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Genet Med 2015 May 175 405 24 doi 10.1038/gim.2015.30.Open DOISearch in Google Scholar

8Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013; 13:59. https://doi.org/10.1186/1471-2431-13-59.Fenton TR Kim JH A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants BMC Pediatr 2013 1359 https://doi.org/10.1186/1471-2431-13-59.10.1186/1471-2431-13-59363747723601190Search in Google Scholar

9Gloyn AL, Odili S, Zelent D, Buettger C, Castleden HAJ, Steele AM et al. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. J Biol Chem. 2005; 280(14): 14105-13. doi: 10.1074/jbc.M413146200Gloyn AL Odili S Zelent D Buettger C Castleden HAJ Steele AM et al Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young J Biol Chem 2005 28014 14105 13 doi 10.1074/jbc.M41314620015677479Open DOISearch in Google Scholar

10Shepherd M, Shields B, Hammersley S, Hudson M, McDonald TJ, Colclough K et al. Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes. Diabetes Care. 2016 Nov; 39(11): 1879-1888. doi: 10.2337/dc16-0645.Shepherd M Shields B Hammersley S Hudson M McDonald TJ Colclough K et al Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes Diabetes Care 2016 Nov 3911 1879 1888 doi 10.2337/dc16-0645.Open DOISearch in Google Scholar

11Aloi C, Salina A, Minuto N, Tallone R, Lugani F, Mascagni A et al. Glucokinase mutations in pediatric patients with impaired fasting glucose. Acta Diabetol. 2017 Oct; 54(10): 913-923. doi: 10.1007/s00592-017-1021-y.Aloi C Salina A Minuto N Tallone R Lugani F Mascagni A et al Glucokinase mutations in pediatric patients with impaired fasting glucose Acta Diabetol 2017 Oct 5410 913 923 doi 10.1007/s00592-017-1021-y.Open DOISearch in Google Scholar

12Osbak KK, Colclough K, Saint-Martin C, Beer NL, Bellanné-Chantelot C, Ellard S, Gloyn AL. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia Hum Mutat. 2009 Nov; 30(11): 1512-26. doi: 10.1002/humu.21110.Osbak KK Colclough K Saint-Martin C Beer NL Bellanné-Chantelot C Ellard S Gloyn AL Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia Hum Mutat 2009 Nov 3011 1512 26 doi 10.1002/humu.2111019790256Open DOISearch in Google Scholar

13Arden C, Trainer A, de la Iglesia N, Scougall ET, Gloyn AL, Lange AJ et al. Cell biological assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity. Diabetes. 2007 Jul; 56(7): 1773-82. doi: 10.2337/db06-1151.Arden C Trainer A de la Iglesia N Scougall ET Gloyn AL Lange AJ et al Cell biological assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity Diabetes 2007 Jul 567 1773 82 doi 10.2337/db06-1151.Open DOISearch in Google Scholar

14Ralph EC, Sun S. Biochemical characterization of MODY2 glucokinase variants V62M and G72R reveals reduced enzymatic activities relative to wild type. Biochemistry. 2009 Mar 24; 48(11): 2514-21. doi: 10.1021/bi900020n.Ralph EC Sun S Biochemical characterization of MODY2 glucokinase variants V62M and G72R reveals reduced enzymatic activities relative to wild type Biochemistry 2009 Mar 24 4811 2514 21 doi 10.1021/bi900020n.Open DOISearch in Google Scholar

15Rhea JM, Molinaro R. Pathology consultation on HbA(1c) methods and interferences. Am J Clin Pathol. 2014 Jan; 141(1): 5-16. doi: 10.1309/AJCPQ23GTT-MLAEVL.Rhea JM Molinaro R Pathology consultation on HbA(1c) methods and interferences Am J Clin Pathol 2014 Jan 1411 5 16 doi 10.1309/AJCPQ23GTT-MLAEVL.Open DOISearch in Google Scholar